Emberi immunhiányt okozó víruspozitív esetek intravénás droghasználók között.

Translated title of the contribution: Human immunodeficiency virus-positive cases among intravenous drug users

József Rácz, E. Újhelyi, Beáta Fehér

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

AIM: The authors show human immunodeficiency virus positive cases among Hungarian intravenous drug users. PATIENTS/METHOD: The cases were identified by self-admittance (by the results of HIV screening), and by objective methods. The persons were studied by questionnaire on their risk behaviours (injecting and sexual behaviours). Treatment seeking (76 cases) and out-of-treatment (121 cases) groups were analysed. In the first group the self-admittance human immunodeficiency virus-status was taken into consideration, in the second group the objective human immunodeficiency virus-status was studied. RESULTS: In the treatment-seeking group three persons knew that they had been human immunodeficiency virus positive or had had Acquired Immunodeficiency Syndrome related disease. The three males were 25 year-old, homeless, and used heroine intravenously. In the out-of-treatment group one person was identified by objective test, who did not know his infection. This 20 year-old male used heroine and amphetamine intravenously, and his risk behaviour was not characteristic for intravenous drug users. CONCLUSION: In these cases the sexual transmission cannot be excluded, but it is pointed out, that the human immunodeficiency virus is present among intravenous drug users in Hungary. Taking into consideration the risk behaviours, these persons can transmit the disease through injecting and or sexual behaviours. In case of treatment seeking group, the treatment institutions (where the interviews took place) did not know the infections among their patients. According to their results, the authors call the attention to the human immunodeficiency virus infection among Hungarian intravenous drug users and they urge specific interventions for intravenous drug users.

Original languageHungarian
Pages (from-to)131-133
Number of pages3
JournalOrvosi Hetilap
Volume143
Issue number3
Publication statusPublished - Jan 20 2002

Fingerprint

Drug Users
HIV
Risk-Taking
Sexual Behavior
Therapeutics
Hungary
Virus Diseases
Amphetamine
Infection
Acquired Immunodeficiency Syndrome
Interviews

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Emberi immunhiányt okozó víruspozitív esetek intravénás droghasználók között. / Rácz, József; Újhelyi, E.; Fehér, Beáta.

In: Orvosi Hetilap, Vol. 143, No. 3, 20.01.2002, p. 131-133.

Research output: Contribution to journalArticle

Rácz, József ; Újhelyi, E. ; Fehér, Beáta. / Emberi immunhiányt okozó víruspozitív esetek intravénás droghasználók között. In: Orvosi Hetilap. 2002 ; Vol. 143, No. 3. pp. 131-133.
@article{b0d2bcec0b7e42e88e2374072880f42d,
title = "Emberi immunhi{\'a}nyt okoz{\'o} v{\'i}ruspozit{\'i}v esetek intrav{\'e}n{\'a}s droghaszn{\'a}l{\'o}k k{\"o}z{\"o}tt.",
abstract = "AIM: The authors show human immunodeficiency virus positive cases among Hungarian intravenous drug users. PATIENTS/METHOD: The cases were identified by self-admittance (by the results of HIV screening), and by objective methods. The persons were studied by questionnaire on their risk behaviours (injecting and sexual behaviours). Treatment seeking (76 cases) and out-of-treatment (121 cases) groups were analysed. In the first group the self-admittance human immunodeficiency virus-status was taken into consideration, in the second group the objective human immunodeficiency virus-status was studied. RESULTS: In the treatment-seeking group three persons knew that they had been human immunodeficiency virus positive or had had Acquired Immunodeficiency Syndrome related disease. The three males were 25 year-old, homeless, and used heroine intravenously. In the out-of-treatment group one person was identified by objective test, who did not know his infection. This 20 year-old male used heroine and amphetamine intravenously, and his risk behaviour was not characteristic for intravenous drug users. CONCLUSION: In these cases the sexual transmission cannot be excluded, but it is pointed out, that the human immunodeficiency virus is present among intravenous drug users in Hungary. Taking into consideration the risk behaviours, these persons can transmit the disease through injecting and or sexual behaviours. In case of treatment seeking group, the treatment institutions (where the interviews took place) did not know the infections among their patients. According to their results, the authors call the attention to the human immunodeficiency virus infection among Hungarian intravenous drug users and they urge specific interventions for intravenous drug users.",
author = "J{\'o}zsef R{\'a}cz and E. {\'U}jhelyi and Be{\'a}ta Feh{\'e}r",
year = "2002",
month = "1",
day = "20",
language = "Hungarian",
volume = "143",
pages = "131--133",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Emberi immunhiányt okozó víruspozitív esetek intravénás droghasználók között.

AU - Rácz, József

AU - Újhelyi, E.

AU - Fehér, Beáta

PY - 2002/1/20

Y1 - 2002/1/20

N2 - AIM: The authors show human immunodeficiency virus positive cases among Hungarian intravenous drug users. PATIENTS/METHOD: The cases were identified by self-admittance (by the results of HIV screening), and by objective methods. The persons were studied by questionnaire on their risk behaviours (injecting and sexual behaviours). Treatment seeking (76 cases) and out-of-treatment (121 cases) groups were analysed. In the first group the self-admittance human immunodeficiency virus-status was taken into consideration, in the second group the objective human immunodeficiency virus-status was studied. RESULTS: In the treatment-seeking group three persons knew that they had been human immunodeficiency virus positive or had had Acquired Immunodeficiency Syndrome related disease. The three males were 25 year-old, homeless, and used heroine intravenously. In the out-of-treatment group one person was identified by objective test, who did not know his infection. This 20 year-old male used heroine and amphetamine intravenously, and his risk behaviour was not characteristic for intravenous drug users. CONCLUSION: In these cases the sexual transmission cannot be excluded, but it is pointed out, that the human immunodeficiency virus is present among intravenous drug users in Hungary. Taking into consideration the risk behaviours, these persons can transmit the disease through injecting and or sexual behaviours. In case of treatment seeking group, the treatment institutions (where the interviews took place) did not know the infections among their patients. According to their results, the authors call the attention to the human immunodeficiency virus infection among Hungarian intravenous drug users and they urge specific interventions for intravenous drug users.

AB - AIM: The authors show human immunodeficiency virus positive cases among Hungarian intravenous drug users. PATIENTS/METHOD: The cases were identified by self-admittance (by the results of HIV screening), and by objective methods. The persons were studied by questionnaire on their risk behaviours (injecting and sexual behaviours). Treatment seeking (76 cases) and out-of-treatment (121 cases) groups were analysed. In the first group the self-admittance human immunodeficiency virus-status was taken into consideration, in the second group the objective human immunodeficiency virus-status was studied. RESULTS: In the treatment-seeking group three persons knew that they had been human immunodeficiency virus positive or had had Acquired Immunodeficiency Syndrome related disease. The three males were 25 year-old, homeless, and used heroine intravenously. In the out-of-treatment group one person was identified by objective test, who did not know his infection. This 20 year-old male used heroine and amphetamine intravenously, and his risk behaviour was not characteristic for intravenous drug users. CONCLUSION: In these cases the sexual transmission cannot be excluded, but it is pointed out, that the human immunodeficiency virus is present among intravenous drug users in Hungary. Taking into consideration the risk behaviours, these persons can transmit the disease through injecting and or sexual behaviours. In case of treatment seeking group, the treatment institutions (where the interviews took place) did not know the infections among their patients. According to their results, the authors call the attention to the human immunodeficiency virus infection among Hungarian intravenous drug users and they urge specific interventions for intravenous drug users.

UR - http://www.scopus.com/inward/record.url?scp=0037138130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037138130&partnerID=8YFLogxK

M3 - Article

VL - 143

SP - 131

EP - 133

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 3

ER -